Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPH0669379B2 - Process for producing cyclohexanecarboxylic acid derivative - Google Patents
[go: Go Back, main page]

JPH0669379B2 - Process for producing cyclohexanecarboxylic acid derivative - Google Patents

Process for producing cyclohexanecarboxylic acid derivative

Info

Publication number
JPH0669379B2
JPH0669379B2 JP13763286A JP13763286A JPH0669379B2 JP H0669379 B2 JPH0669379 B2 JP H0669379B2 JP 13763286 A JP13763286 A JP 13763286A JP 13763286 A JP13763286 A JP 13763286A JP H0669379 B2 JPH0669379 B2 JP H0669379B2
Authority
JP
Japan
Prior art keywords
cep
ester
reaction
formula
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP13763286A
Other languages
Japanese (ja)
Other versions
JPS62294091A (en
Inventor
宏紀 黒田
彰彦 宮寺
徹 金内
Original Assignee
第一製薬株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 第一製薬株式会社 filed Critical 第一製薬株式会社
Priority to JP13763286A priority Critical patent/JPH0669379B2/en
Publication of JPS62294091A publication Critical patent/JPS62294091A/en
Publication of JPH0669379B2 publication Critical patent/JPH0669379B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

【発明の詳細な説明】 <産業上の利用分野> 本発明は胃炎・胃潰瘍治療剤及び抗ブラスミン剤として
優れた作用を有するトランス−4−アミノメチルシクロ
ヘキサンカルボン酸−4′−(2″−カルボキシエチ
ル)フェニルエステル(以下、CEPエステルと称する)
の新規且つ工業的に有利な製法に関する。
DETAILED DESCRIPTION OF THE INVENTION <Field of Industrial Application> The present invention relates to trans-4-aminomethylcyclohexanecarboxylic acid-4 ′-(2 ″ -carboxy), which has excellent effects as a therapeutic agent for gastritis / gastric ulcer and an anti-brasmin agent. Ethyl) phenyl ester (hereinafter referred to as CEP ester)
The present invention relates to a novel and industrially advantageous production method.

<従来の技術> CEPエステルの製造法として、その末端のカルボキシル
基を保護した原料化合物より保護基を脱離させる方法が
知られている。該方法としては(1)接触還元による方
法(特公昭46−19950及び特公昭52−48978号公報)、
(2)酸−アルカリ加水分解による方法(特開昭52−17
447及び特開昭53−56642号公報)及び(3)ルイス酸−
求核試剤による方法(特開昭56−167648号公報)をあげ
ることができる。
<Prior Art> As a method for producing a CEP ester, a method is known in which a protecting group is eliminated from a raw material compound in which a terminal carboxyl group is protected. The method includes (1) a method by catalytic reduction (Japanese Patent Publication No. 46-19950 and Japanese Patent Publication No. 52-48978),
(2) Method by acid-alkali hydrolysis (JP-A-52-17)
447 and JP-A-53-56642) and (3) Lewis acid-
A method using a nucleophilic reagent (JP-A-56-167648) can be mentioned.

しかしながら、これらの方法は以下のような欠点を有す
る。
However, these methods have the following drawbacks.

即ち、(1)の方法では、パラジウム等の高価な触媒が
必要であり、又水素ガスを加圧状態で反応させなければ
ならないことから安全性上問題があり、更に特殊な装置
を必要とする。(2)の方法ではCEPエステルの分子中
央部のエステルが加水分解されやすく、又原料化合物の
回数が繁雑である。(3)の方法では、使用する金属類
の後処理が繁雑である。
That is, in the method (1), an expensive catalyst such as palladium is required, and since hydrogen gas must be reacted in a pressurized state, there is a safety problem, and a special device is required. . In the method (2), the ester at the center of the molecule of the CEP ester is easily hydrolyzed and the number of raw material compounds is complicated. In the method (3), the post-treatment of the metals used is complicated.

<発明が解決しようとする問題点> 本発明者等は、上記欠点を解決すべく鋭意検討した結
果、本発明を完成した。
<Problems to be Solved by the Invention> The present inventors have completed the present invention as a result of intensive studies to solve the above-mentioned drawbacks.

<発明の構成> 本発明は、一般式(I) (式中、Rは置換基を有することもあるベンジル基、フ
ェニル基又は低級アルキル基を示す。)で表わされる化
合物をCEPエステルに変換する能力を有し且つアスペル
ギルス属もしくはムコール属に属する微生物の菌体、培
養物又はこれらの分画物の存在下、上記式(I)の化合
物又はその塩を処理することを特徴とするCEPエステル
又はその塩の製造法に関する。
<Structure of Invention> The present invention has the general formula (I) (In the formula, R represents a benzyl group which may have a substituent, a phenyl group or a lower alkyl group.) A compound having the ability to convert into a CEP ester and belonging to the genus Aspergillus or Mucor. The present invention relates to a method for producing a CEP ester or a salt thereof, which comprises treating the compound of the above formula (I) or a salt thereof in the presence of cells, a culture, or a fraction thereof.

式(I)においてベンジル基の置換基としては、ハロゲ
ン原子、低級アルキル基、ニトロ基等をあげることがで
きる。
Examples of the substituent of the benzyl group in the formula (I) include a halogen atom, a lower alkyl group and a nitro group.

又、式(I)の置換基Rについてはベンジル基が好まし
い。
Further, as the substituent R in the formula (I), a benzyl group is preferable.

式(I)の化合物の塩としては塩酸、硫酸等の無機酸等
との酸付加塩があげられる。又、CEPエステルの塩とし
ては塩酸、硫酸等の無機酸等との酸付加塩をあげること
がてきる。
Examples of the salt of the compound of formula (I) include acid addition salts with inorganic acids such as hydrochloric acid and sulfuric acid. As the salt of CEP ester, an acid addition salt with an inorganic acid such as hydrochloric acid or sulfuric acid may be mentioned.

アスペルギルス属の微生物の好ましい種としてはアスペ
ルギルス ニガー(Aspergillus nigar)及びアスペル
ギルス オリゼア(Aspergillus oryzae)等を、又、
ムコール属の微生物の好ましい種としてはムコール ヤ
ポニクス(Mucorjaponicus)等をあげることができる。
Preferred species of Aspergillus microorganisms include Aspergillus nigar and Aspergillus oryzae,
Examples of preferable microorganisms of the genus Mucor include Mucor japonicus.

培養物としては、上記微生物を適当な培地で培養したも
のをあげることができる。
Examples of the culture include those obtained by culturing the above microorganism in an appropriate medium.

前記微生物の分画物としては、菌体又は培養物を水もし
くは適当な緩衝液で抽出したもの、流体培地で培養を行
った場合には培養物の濾液、該抽出液もしくは濾液に硫
安もしくはアルコールを加えることにより得られる沈殿
物及び該抽出液もしくは濾液をゲル濾過,限外濾過,イ
オン交換クロマトグラフィー等を用いて分画したもの並
びに菌体の破砕物及び該破砕物を前記の分画方法を用い
て分画したものをあげることができる。このような分画
物の一部については酵素製剤として市販されているもの
がある。該酵素製剤としては、リパーゼM−AP,ペクチ
ナーゼPL,ペクチナーゼ G,セルラーゼ(I),セルラ
ーゼ(II),セルラーゼ,スミチームAC等を、好ましく
はスミチームAC及びリバーゼM−APをあげることができ
る。一般には、簡便性から市販の酵素製剤の存在下反応
を行うことが好ましい。
Examples of the fraction of the microorganism include cells or cultures extracted with water or an appropriate buffer, a culture filtrate when cultured in a fluid medium, ammonium sulfate or alcohol in the extract or filtrate. The precipitate obtained by the addition of the precipitate and the extract or filtrate obtained by fractionation using gel filtration, ultrafiltration, ion exchange chromatography, etc., and crushed bacterial cells and the crushed product described above. What was fractionated using can be mentioned. Some of these fractions are commercially available as enzyme preparations. Examples of the enzyme preparation include lipase M-AP, pectinase PL, pectinase G, cellulase (I), cellulase (II), cellulase, sumizyme AC and the like, preferably sumezyme AC and ribase M-AP. In general, it is preferable to carry out the reaction in the presence of a commercially available enzyme preparation for the sake of simplicity.

本発明の反応は、通常水又は適当な緩衝液pHを約4〜5
に保ちながら20〜40℃の温度,好ましくは25〜30℃で5
〜20時間,好ましくは10〜15時間行われる。前記緩衝液
としてはリン酸及びクエン酸緩衝液等があげられる。原
料である式(I)の化合物の反応液中における濃度は通
常8%(w/v)以下が適当である。反応を市販の酵素
製剤の存在下行った場合には、該酵素製剤は原料である
式(I)の化合物1重量部に対し、通常約1〜1/50重
量部使用される。
The reaction of the present invention is usually carried out with water or a suitable buffer pH of about 4-5.
5 to 20 to 40 ° C, preferably 25 to 30 ° C.
It is carried out for up to 20 hours, preferably 10 to 15 hours. Examples of the buffer solution include phosphoric acid and citrate buffer solutions. A suitable concentration of the compound of formula (I) as a raw material in the reaction solution is usually 8% (w / v) or less. When the reaction is carried out in the presence of a commercially available enzyme preparation, the enzyme preparation is usually used in an amount of about 1/50 parts by weight per 1 part by weight of the compound of the formula (I) as a raw material.

反応終了後、反応液のpHを7付近に調整するとCEPエス
テルが析出するのでこれを濾取する。次いで得られた結
晶を水で洗浄するか或いは水及びイソプロピルアルコー
ルの混合液又はpH約2.5の水溶液に溶解させた後活性炭
又は非イオン性多孔性ポリマー樹脂と処理し、次いで水
等を用いて晶析させることにより高純度のCEPエステル
を得ることができる。
After completion of the reaction, if the pH of the reaction solution is adjusted to around 7, the CEP ester will precipitate, and this is collected by filtration. Then, the obtained crystals are washed with water or dissolved in a mixed solution of water and isopropyl alcohol or an aqueous solution having a pH of about 2.5, treated with activated carbon or a nonionic porous polymer resin, and then crystallized with water or the like. High-purity CEP ester can be obtained by precipitation.

<発明の効果> 本発明の製法は、緩和な条件下、CEPエステルの中央部
フェニルエステルの分解を伴うことなく、目的とするCE
Pエステルを高純度かつ高収率で得ることができる。
又、本発明の製法は操作上特別な装置を必要とすること
なく、安全性に優れ、かつ後処理の面でも有利である。
従って、本発明の製法は工業的製法として優れたもので
ある。
<Effects of the Invention> The production method of the present invention, under mild conditions, does not involve decomposition of the central phenyl ester of the CEP ester, and the target CE
The P ester can be obtained with high purity and high yield.
Further, the production method of the present invention does not require a special device in operation, is excellent in safety, and is advantageous in terms of post-treatment.
Therefore, the manufacturing method of the present invention is excellent as an industrial manufacturing method.

次に本発明を参考例及び実施例により説明するが、本発
明はこれらによって限定されるものではない。
Next, the present invention will be described with reference to Reference Examples and Examples, but the present invention is not limited thereto.

尚、実施例中においてトランス−4−アミノメチルシク
ロヘキサンカルボン酸−4′−(2″−カルボキシエチ
ル)フェニルエステルをCEPエステルと、その塩酸塩をC
EPエステル塩酸塩と記す。
In the examples, trans-4-aminomethylcyclohexanecarboxylic acid-4 '-(2 "-carboxyethyl) phenyl ester is CEP ester, and its hydrochloride is C
It is referred to as EP ester hydrochloride.

参考例1 小麦▲麩▼250gを水250mlに懸濁した。この懸濁液を滅
菌処理した後アスペルギルス ニガーの菌体を接種し、
30℃で4日間培養した。培養後、蒸留水2を加え30℃
で3時間撹拌した後濾過した。濾液を遠心分離し、その
上澄液を限外濾過にて濃縮し、濃縮液200mlを得た。
Reference Example 1 250 g of wheat flour was suspended in 250 ml of water. After sterilizing this suspension, inoculate the cells of Aspergillus niger,
It was cultured at 30 ° C for 4 days. After culturing, add distilled water 2 to 30 ℃
After stirring for 3 hours, the mixture was filtered. The filtrate was centrifuged and the supernatant was concentrated by ultrafiltration to obtain 200 ml of concentrated liquid.

参考例2 アスペルギルス オリゼアを用いて参考例1と同様に培
養し、処理して濃縮液200mlを得た。
Reference Example 2 Using Aspergillus oryzae, the cells were cultured and treated in the same manner as in Reference Example 1 to obtain 200 ml of a concentrated solution.

参考例3 コーンスティーブリカー15g,可溶性デンプン5g,大豆粉5
g,リン酸第二水素カリウム1g,塩化カリウム0.25gを水に
懸濁した後pHを5に調整しながら全量を500mlに調整し
た。この懸濁液を滅菌した後ムコール ヤボニクスの菌
体を接種し26℃で46時間振盪培養した。培養液を濾過し
た後、濾液500mlに硫安を70%飽和まで加え、遠心分離
した。得られた沈査に蒸留水50mlを加えた後常法に従い
透析を行い水溶液100mlを得た。
Reference Example 3 Corn steep liquor 15 g, soluble starch 5 g, soybean flour 5
After suspending g, potassium dihydrogen phosphate 1 g, and potassium chloride 0.25 g in water, the total amount was adjusted to 500 ml while adjusting the pH to 5. After this suspension was sterilized, Mucor Yavonix cells were inoculated and cultured at 26 ° C. for 46 hours with shaking. After filtering the culture broth, ammonium sulfate was added to 500 ml of the filtrate to 70% saturation, and the mixture was centrifuged. Distilled water (50 ml) was added to the obtained precipitate, and dialyzed according to a conventional method to obtain 100 ml of an aqueous solution.

実施例1 トランス−4−アミノメチルシクロヘキサンカルボン酸
−4′−(2″−ベンジルオキシカルボニルエチル)フ
ェニルエステル塩酸塩(以下、化合物Aと略す)48gを
水1,200mlに懸濁し、スミチームAC(新日本化学工業社
製)0.96gを加え、30℃で15時間撹拌した。反応系内は1
N水酸化ナトリウムでpH4〜4.5に保った。
Example 1 48 g of trans-4-aminomethylcyclohexanecarboxylic acid-4 '-(2 "-benzyloxycarbonylethyl) phenyl ester hydrochloride (hereinafter abbreviated as compound A) was suspended in 1200 ml of water, and Sumizyme AC (new 0.96 g (manufactured by Nippon Kagaku Kogyo Co., Ltd.) was added, and the mixture was stirred at 30 ° C. for 15 hours.
The pH was kept at 4-4.5 with N sodium hydroxide.

反応終了液を高速液体クロマトグラフィーで分析したと
ころCEPエステルの生成率は99.5%であった。
When the reaction completed liquid was analyzed by high performance liquid chromatography, the production rate of CEP ester was 99.5%.

反応液をpH7に調整し、析出結果を濾取した。洗浄後乾
燥してCEPエステル33.0g(収率97.4%)を得た。
The reaction solution was adjusted to pH 7 and the precipitation result was collected by filtration. After washing and drying, 33.0 g of CEP ester (yield 97.4%) was obtained.

得られたCEPエステルをイソプロピルアルコール−水混
液に懸濁し塩酸でpH2.5に調整し、活性炭処理した。澄
明濾液を減圧濃縮し、析出晶を濾取、乾燥してCEPエス
テル塩酸塩35.7g(収率94.1%)を得た。
The obtained CEP ester was suspended in an isopropyl alcohol-water mixed solution, adjusted to pH 2.5 with hydrochloric acid, and treated with activated carbon. The clear filtrate was concentrated under reduced pressure, and the precipitated crystals were collected by filtration and dried to obtain CEP ester hydrochloride (35.7 g, yield 94.1%).

本品の薄層クロマトグラフィー,液体クロマトグラフィ
ー,IR,NMRは標品と完全に一致した。又、本品の純度を
液体クロマトグラフィーで検討したところ99.9%であっ
た。
Thin-layer chromatography, liquid chromatography, IR, and NMR of this product were completely consistent with those of the standard product. The purity of this product was 99.9% when examined by liquid chromatography.

実施例2 スミチームAC 0.96gの代りにペクチナームPL4.8gを使
用する他は全て実施例1と同様に反応させた。
Example 2 The same reaction as in Example 1 was carried out except that 4.8 g of Pectinam PL was used instead of 0.96 g of Sumizyme AC.

反応終了液を高速液体クロマトグラフィーで分析したと
ころCEPエステルの生成率は98.7%であった。
When the reaction completed liquid was analyzed by high performance liquid chromatography, the production rate of CEP ester was 98.7%.

反応液を実施例1と同様に処理しCEPエステル塩酸塩33.
7gを得た。
The reaction mixture was treated as in Example 1 to give CEP ester hydrochloride 33.
I got 7g.

実施例3 化合物 A 24gに水600ml及び参考例1で得られた濃縮
液80mlを加え、反応系内をpH4〜4.5に保ちながら30℃で
15時間撹拌した。反応液を高速液体クロマトグラフィー
で分析したところCEPエステルの生成率は99.0%であっ
た。
Example 3 To 24 g of Compound A, 600 ml of water and 80 ml of the concentrate obtained in Reference Example 1 were added, and the reaction system was maintained at pH 4 to 4.5 at 30 ° C.
Stir for 15 hours. When the reaction solution was analyzed by high performance liquid chromatography, the production rate of CEP ester was 99.0%.

得られた反応液を実施例1と同様に処理してCEPエステ
ル塩酸塩17.1gを得た。
The obtained reaction solution was treated in the same manner as in Example 1 to obtain 17.1 g of CEP ester hydrochloride.

実施例4 参考例2で得られた濃縮液を用いて実施例3と同様に反
応させた。
Example 4 The same reaction as in Example 3 was carried out using the concentrated liquid obtained in Reference Example 2.

反応液を高速液体クロマトグラフィーで分析したところ
CEPエステルの生成率は98.6%であった。
When the reaction solution was analyzed by high performance liquid chromatography
The production rate of CEP ester was 98.6%.

得られた反応液を実施例1と同様に処理してCEPエステ
ル塩酸塩16.4%を得た。
The obtained reaction solution was treated in the same manner as in Example 1 to obtain CEP ester hydrochloride (16.4%).

実施例5 化合物 A 24gに0.2Mクエン酸緩衝液(pH5)600ml及
びリバーゼM−AP−10(天野製薬社製)6gを加え、30℃
で15時間撹拌した。
Example 5 To 24 g of Compound A, 600 ml of 0.2 M citrate buffer (pH 5) and 6 g of Rebase M-AP-10 (manufactured by Amano Pharmaceutical Co., Ltd.) were added, and the mixture was added at 30 ° C.
The mixture was stirred for 15 hours.

反応終了液を高速液体クロマトグラフィーで分析したと
ころCEPエステルの生成率は99.7%であった。
When the reaction completed liquid was analyzed by high performance liquid chromatography, the production rate of CEP ester was 99.7%.

次いで反応液をpH7に調整後、析出結晶を濾取した。得
られた結晶を水1,900mlに懸濁し、塩酸でpH2.8に調整後
活性炭処理を行った。濾液に非イオン性多孔性ポリマー
樹脂(ダイヤイオン HP−10(三菱化成社製))35mlを
加え撹拌後濾過した。濾液を減圧濃縮し、析出した結晶
を濾取、乾燥してCEPエステル塩酸塩16.9gを得た。
Next, the reaction solution was adjusted to pH 7, and the precipitated crystals were collected by filtration. The obtained crystals were suspended in 1,900 ml of water, adjusted to pH 2.8 with hydrochloric acid, and treated with activated carbon. 35 ml of a nonionic porous polymer resin (Diaion HP-10 (manufactured by Mitsubishi Kasei)) was added to the filtrate, and the mixture was stirred and filtered. The filtrate was concentrated under reduced pressure, and the precipitated crystals were collected by filtration and dried to obtain 16.9 g of CEP ester hydrochloride.

実施例6 化合物 A 24gに0.2Mクエン酸緩衝液(pH5)600ml及
び参考例3で得られた水溶液25mlを加え、30℃で15時間
撹拌した。
Example 6 To 24 g of Compound A, 600 ml of 0.2 M citrate buffer (pH 5) and 25 ml of the aqueous solution obtained in Reference Example 3 were added, and the mixture was stirred at 30 ° C. for 15 hours.

反応終了液を高速液体クロマトグラフィーで分析したと
ころCEPエステルの生成率は98.5%であった。
When the reaction completed liquid was analyzed by high performance liquid chromatography, the production rate of CEP ester was 98.5%.

得られた反応液を実施例5と同様に後処理してCEPエス
テル塩酸塩16.1gを得た。
The resulting reaction solution was post-treated in the same manner as in Example 5 to obtain 16.1 g of CEP ester hydrochloride.

実施例7 トランス−4−アミノメチルシクロヘキサンカルボン酸
−4′−(2″−エトキシカルボニルエチル)フエニル
エステル塩酸塩18.5gに0.05Mクエン酸緩衝液(pH4.5)4
60ml及びスミチームAC 18.5gを加え、30℃で15時間撹
拌した。
Example 7 Trans-4-Aminomethylcyclohexanecarboxylic acid-4 '-(2 "-ethoxycarbonylethyl) phenyl ester hydrochloride 18.5 g 0.05 M citrate buffer (pH 4.5) 4
60 ml and Sumizyme AC 18.5 g were added, and the mixture was stirred at 30 ° C. for 15 hours.

反応終了液を高速液体クロマトグラフィーで分析したと
ころCEPエステルの生成率は96.5%であった。
When the reaction completed liquid was analyzed by high performance liquid chromatography, the production rate of CEP ester was 96.5%.

得られた反応液を実施例1と同様に後処理してCEPエス
テル塩酸塩14.7gを得た。
The obtained reaction solution was post-treated in the same manner as in Example 1 to obtain 14.7 g of CEP ester hydrochloride.

実施例8 トランス−4−アミノメチルシクロヘキサンカルボン酸
−4′−(2″−メトキシカルボニルエチル)フェニル
エステル塩酸塩17.8gに0.05Mクエン酸緩衝液(pH4.5)
1.780ml及びスミチームAC 17.8gを加え、30℃で15時間
撹拌した。
Example 8 trans-4-Aminomethylcyclohexanecarboxylic acid-4 '-(2 "-methoxycarbonylethyl) phenyl ester hydrochloride 17.8 g 0.05% citrate buffer (pH 4.5)
1.780 ml and Sumiteam AC 17.8 g were added, and the mixture was stirred at 30 ° C. for 15 hours.

反応終了液を高速液体クロマトグラフィーで分析したと
ころCEPエステルの生成率は95.2%であった。
When the reaction completed liquid was analyzed by high performance liquid chromatography, the production rate of CEP ester was 95.2%.

得られた反応液を実施例1と同様に後処理してCEPエス
テル塩酸塩14.3gを得た。
The obtained reaction solution was post-treated in the same manner as in Example 1 to obtain CEP ester hydrochloride (14.3 g).

実施例9 トランス−4−アミノメチルシクロヘキサンカルボン酸
−4′−(2″−フェノキシカルボニルエチル)フェニ
ルエステル塩酸塩20.9gに0.05Mクエン酸緩衝液(pH4.
5)2,000ml及びスミチームAC 6gを加え、30℃で15時間
撹拌した。
Example 9 trans-4-Aminomethylcyclohexanecarboxylic acid-4 '-(2 "-phenoxycarbonylethyl) phenyl ester hydrochloride 20.9 g in 0.05M citrate buffer (pH 4.
5) 2,000 ml and 6 g of Sumizyme AC were added, and the mixture was stirred at 30 ° C for 15 hours.

反応終了液を高速液体クロマトグラフィーで分析したと
ころCEPエステルの生成率は98.6%であった。
When the reaction completed liquid was analyzed by high performance liquid chromatography, the production rate of CEP ester was 98.6%.

得られた反応液を実施例1と同様に後処理してCEPエス
テル塩酸塩14.0gを得た。
The obtained reaction solution was post-treated in the same manner as in Example 1 to obtain 14.0 g of CEP ester hydrochloride.

実施例10 トランス−4−アミノメチルシクロヘキサンカルボン酸
−4′−(2″−p−ニトロベンジルオキシカルボニル
エチル)フェニルエステル塩酸塩 23.2gに0.05Mクエン
酸緩衝液(pH4.5)2,320ml及びスミチームAC 23.2gを
加え、30℃で15時間撹拌した。
Example 10 trans-4-Aminomethylcyclohexanecarboxylic acid-4 '-(2 "-p-nitrobenzyloxycarbonylethyl) phenyl ester hydrochloride 23.2 g, 0.05M citrate buffer (pH 4.5) 2,320 ml and Sumizyme AC23.2g was added and it stirred at 30 degreeC for 15 hours.

反応終了液を高速液体クロマトグラフィーで分析したと
ころCEPエステルの生成率は95.1%であった。
When the reaction completed liquid was analyzed by high performance liquid chromatography, the production rate of CEP ester was 95.1%.

得られた反応液を実施例1と同様に後処理してCEPエス
テル塩酸塩13.9gを得た。
The obtained reaction solution was post-treated in the same manner as in Example 1 to obtain 13.9 g of CEP ester hydrochloride.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.5 識別記号 庁内整理番号 FI 技術表示箇所 (C12P 13/00 C12R 1:785) ─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 5 Identification code Internal reference number FI technical display location (C12P 13/00 C12R 1: 785)

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】式(I) (式中、Rは置換基を有することもあるベンジル基、フ
ェニル基又は低級アルキル基を示す。)で表わされる化
合物をトランス−4−アミノメチルシクロヘキサンカル
ボン酸−4′−(2″−カルボキシエチル)フェニルエ
ステルに変換する能力を有し且つアスペルギルス属もし
くはムコール属に属する微生物の菌体、培養物又はこれ
らの分画物の存在下、式(I)で表わされる化合物又は
その塩を処理することを特徴とするトランス−4−アミ
ノメチルシクロヘキサンカルボン酸−4′−(2″−カ
ルボキシエチル)フェニルエステル及びその塩の製造法
1. A formula (I) (In the formula, R represents a benzyl group which may have a substituent, a phenyl group or a lower alkyl group.) A compound represented by trans-4-aminomethylcyclohexanecarboxylic acid-4 '-(2 "-carboxyethyl) ) Treating the compound represented by formula (I) or a salt thereof in the presence of a microorganism, a culture, or a fraction thereof of a microorganism belonging to the genus Aspergillus or the genus Mucor having the ability to convert to a phenyl ester. For producing trans-4-aminomethylcyclohexanecarboxylic acid-4 '-(2 "-carboxyethyl) phenyl ester and salts thereof
JP13763286A 1986-06-13 1986-06-13 Process for producing cyclohexanecarboxylic acid derivative Expired - Lifetime JPH0669379B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP13763286A JPH0669379B2 (en) 1986-06-13 1986-06-13 Process for producing cyclohexanecarboxylic acid derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13763286A JPH0669379B2 (en) 1986-06-13 1986-06-13 Process for producing cyclohexanecarboxylic acid derivative

Publications (2)

Publication Number Publication Date
JPS62294091A JPS62294091A (en) 1987-12-21
JPH0669379B2 true JPH0669379B2 (en) 1994-09-07

Family

ID=15203184

Family Applications (1)

Application Number Title Priority Date Filing Date
JP13763286A Expired - Lifetime JPH0669379B2 (en) 1986-06-13 1986-06-13 Process for producing cyclohexanecarboxylic acid derivative

Country Status (1)

Country Link
JP (1) JPH0669379B2 (en)

Also Published As

Publication number Publication date
JPS62294091A (en) 1987-12-21

Similar Documents

Publication Publication Date Title
Ståhl et al. The synthesis of a D-amino acid ester in an organic media with α-chymotrypsin modified by a bio-imprinting procedure
KR102301469B1 (en) Production of galacto-oligosaccharides
CA1052716A (en) Process for the enzymatic resolution of dl-phenyl glycine amide into its optically active antipodes
JPS5836399A (en) Production of human insulin derivative
JPH0411194B2 (en)
JPH0669379B2 (en) Process for producing cyclohexanecarboxylic acid derivative
US4065353A (en) Method for the preparation of D-carbamyl aminoacids and the corresponding D-aminoacids
JP2886576B2 (en) Preparation of cyclohexanecarboxylic acid derivatives
CN118165946A (en) Biosynthesis method of norepinephrine bitartrate
JP2892038B2 (en) Preparation of phenylpropionic acid derivatives
JP2783823B2 (en) Preparation of cyclohexanecarboxylic acid derivatives
US3975235A (en) Process for the production of cephamycin type antibiotic substances
JP2721536B2 (en) Method for obtaining D-β-hydroxy amino acid
JP2771823B2 (en) Preparation of cyclohexanecarboxylic acid derivatives
JPH03236788A (en) Production of glycoside by enzymatic method
JPWO1996031616A1 (en) Method for producing L-2-aminoadipic acid
JP2690779B2 (en) L-ascorbic acid derivative and method for producing the same
JP2666060B2 (en) Method for producing N-acetylchitooligosaccharide derivative
JP4336400B2 (en) Enzyme inducer and enzyme production method using the same
JPH0817718B2 (en) Method for producing D-(-)-tartaric acid
JP3345551B2 (en) Method for producing S-phenyl-L-cysteine
JP3183764B2 (en) Method for producing optically active 3-chloro-1,2-propanediol derivative
CN117947123A (en) Method for preparing L-thioproline
CN119307565A (en) A method for synthesizing L-7-methyltryptophan by enzymatic method
KR20050042490A (en) Process for producing optically active erythro 3-cyclohexylserines

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term